Roche Holding AG (Roche Holding AG) Purchase Of Investment

: $-958 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

Roche Holding AG's purchase of investment for the six months ended in Dec. 2023 was $-867 Mil. It means Roche Holding AG spent $867 Mil on purchasing investments. Roche Holding AG's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $-958 Mil.

Compared with last quarter ($-91 Mil in Jun. 2023 ), Roche Holding AG spent more money on purchasing investments in Dec. 2023 ($-867 Mil).

Roche Holding AG Purchase Of Investment Historical Data

The historical data trend for Roche Holding AG's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-224.91

-1,519.59

-218.24

-290.90

-962.07

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Purchase Of Investment	Get a 7-Day Free Trial															-110.75	-136.05	-149.21	-91.07	-867.25

Roche Holding AG Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-958 Mil.

Roche Holding AG Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.